SCHEMBL8850480

SCHEMBL8850480

CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)c(O)c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 14/20 0.80
▸ ADRB1 P08588 7/20 0.64
▸ MAPK1 P28482 7/20 0.64
▸ KDM4E B2RXH2 6/20 0.64
▸ ADRA1A P35348 6/20 0.64
▸ HSD17B10 Q99714 6/20 0.64
▸ LMNA P02545 5/20 0.64
▸ CYP3A4 P08684 5/20 0.64
▸ ADRA1D P25100 4/20 0.64
▸ SLC6A2 P23975 4/20 0.64
▸ SLC6A4 P31645 4/20 0.64
▸ HIF1A Q16665 4/20 0.64
▸ TSHR P16473 4/20 0.64
▸ CYP2D6 P10635 4/20 0.64
▸ DRD3 P35462 3/20 0.64
▸ CYP1A2 P05177 3/20 0.64
▸ NFKB1 P19838 3/20 0.64
▸ ADRA2A P08913 3/20 0.64
▸ ADORA3 P0DMS8 3/20 0.64
▸ OPRM1 P35372 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butopamine SCHEMBL122463 0.89 ADRB2 (1.00) ADRB2ADRB1MAPK1ADRA1AHSD17B10
Ractopamine SCHEMBL9757702 0.89 ADRB2 (1.00) ADRB2ADRB1MAPK1ADRA1AHSD17B10
Ractopamine SCHEMBL10659583 0.89 ADRB2 (1.00) ADRB2ADRB1MAPK1ADRA1AHSD17B10
Ractopamine SCHEMBL144797 0.89 ADRB2 (1.00) ADRB2ADRB1MAPK1ADRA1AHSD17B10
Ractopamine SCHEMBL8851800 0.88 ADRB2 (0.97) ADRB2ADRB1MAPK1KDM4EADRA1A
Ractopamine SCHEMBL350754 0.88 ADRB2 (0.97) ADRB2ADRB1MAPK1KDM4EADRA1A
Butopamine SCHEMBL11471316 0.88 ADRB2 (0.97) ADRB2ADRB1MAPK1ADRA1AHSD17B10
Ractopamine SCHEMBL11471317 0.88 ADRB2 (0.97) ADRB2ADRB1MAPK1ADRA1AHSD17B10
Butopamine SCHEMBL351104 0.88 ADRB2 (0.97) ADRB2ADRB1MAPK1KDM4EADRA1A
Ractopamine SCHEMBL8892153 0.88 ADRB2 (0.97) ADRB2ADRB1MAPK1KDM4EADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0658538-B1 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist GENSIA INC (US) 1997-10-29 — — EP disclosed
Send feedback